Pages that link to "Q30976289"

The following pages link to Incidence of exudative age-related macular degeneration among elderly Americans (Q30976289):

Displaying 33 items.

• Scanning laser entoptic perimetry for the detection of age-related macular degeneration (Q31126206) (← links)
• Retinal diseases in a tertiary hospital: the need for establishment of a vitreo-retinal care unit (Q33386095) (← links)
• Resource use and costs associated with diabetic macular edema in elderly persons (Q33390920) (← links)
• Cigarette Smoke-Related Hydroquinone Dysregulates MCP-1, VEGF and PEDF Expression in Retinal Pigment Epithelium in Vitro and in Vivo (Q33840832) (← links)
• Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular deg (Q34086893) (← links)
• Resource utilization and costs of age-related macular degeneration. (Q34328499) (← links)
• Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes (Q34656454) (← links)
• Nicotine Increases the VEGF/PEDF Ratio in Retinal Pigment Epithelium: A Possible Mechanism for CNV in Passive Smokers with AMD (Q35027712) (← links)
• Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network (Q35127011) (← links)
• Inhibition of proliferation, migration and invasiveness of endothelial murine cells culture induced by resveratrol. (Q35631662) (← links)
• Cost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMD (Q35923674) (← links)
• Immune mechanisms in inflammatory and degenerative eye disease (Q36040908) (← links)
• Current progress of siRNA/shRNA therapeutics in clinical trials (Q36071638) (← links)
• Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study. (Q36075546) (← links)
• Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons (Q36223814) (← links)
• Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury. (Q36634698) (← links)
• Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. (Q36740561) (← links)
• Longitudinal incidence of adverse outcomes of age-related macular degeneration. (Q36753960) (← links)
• Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy (Q37095340) (← links)
• Is age-related macular degeneration associated with stroke among elderly americans? (Q37206264) (← links)
• Identification of persons with incident ocular diseases using health care claims databases (Q37333129) (← links)
• A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration (Q37351663) (← links)
• Oxidative damage-induced inflammation initiates age-related macular degeneration. (Q37357471) (← links)
• Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File (Q37839380) (← links)
• Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. (Q39244149) (← links)
• Impact of HMG‐CoA reductase inhibition on oxidant‐induced injury in human retinal pigment epithelium cells (Q39547616) (← links)
• Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. (Q39834593) (← links)
• Light, lipids and photoreceptor survival: live or let die? (Q40703905) (← links)
• Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration (Q42012939) (← links)
• Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model (Q43151578) (← links)
• The Finnish national guideline for diagnosis, treatment and follow-up of patients with wet age-related macular degeneration (Q50903375) (← links)
• Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration. (Q51736915) (← links)
• An epidemiological investigation of age-related macular degeneration in aged population in China: the Hainan study (Q59524799) (← links)